Format

Send to

Choose Destination
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1064-1073. doi: 10.1164/rccm.201711-2348OC.

Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.

Author information

1
1 Division of Allergy, Pulmonary, and Critical Care Medicine and.
2
2 Infectious Disease Group, J. Craig Venter Institute, Rockville, Maryland; and.
3
3 Department of Pediatrics, Emory University, Atlanta, Georgia.
4
4 Department of Biostatistics, and.
5
5 Division of Infectious Diseases, Department of Medicine.
6
6 Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.

Abstract

RATIONALE:

Recurrent wheeze and asthma are thought to result from alterations in early life immune development following respiratory syncytial virus (RSV) infection. However, prior studies of the nasal immune response to infection have assessed only individual cytokines, which does not capture the whole spectrum of response to infection.

OBJECTIVES:

To identify nasal immune phenotypes in response to RSV infection and their association with recurrent wheeze.

METHODS:

A birth cohort of term healthy infants born June to December were recruited and followed to capture the first infant RSV infection. Nasal wash samples were collected during acute respiratory infection, viruses were identified by RT-PCR, and immune-response analytes were assayed using a multianalyte bead-based panel. Immune-response clusters were identified using machine learning, and association with recurrent wheeze at age 1 and 2 years was assessed using logistic regression.

MEASUREMENTS AND MAIN RESULTS:

We identified two novel and distinct immune-response clusters to RSV and human rhinovirus. In RSV-infected infants, a nasal immune-response cluster characterized by lower non-IFN antiviral immune-response mediators, and higher type-2 and type-17 cytokines was significantly associated with first and second year recurrent wheeze. In comparison, we did not observe this in infants with human rhinovirus acute respiratory infection. Based on network analysis, type-2 and type-17 cytokines were central to the immune response to RSV, whereas growth factors and chemokines were central to the immune response to human rhinovirus.

CONCLUSIONS:

Distinct immune-response clusters during infant RSV infection and their association with risk of recurrent wheeze provide insights into the risk factors for and mechanisms of asthma development.

KEYWORDS:

human rhinovirus; immune response; respiratory syncytial virus; systems approach; wheeze

PMID:
29733679
PMCID:
PMC6221572
[Available on 2019-10-15]
DOI:
10.1164/rccm.201711-2348OC

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center